Genewity B.V

Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field

Genewity b.v operates in the Biotechnology research industry.

Genewity b.v's revenue is 11m - 100m

Genewity b.v has 11 - 50 employees.